Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia

NCT03865290 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Indigestion
Diabetes Mellitus

Interventions

DRUG: Ondansetron 8mg
DRUG: Placebo

Sponsor

Mayo Clinic

Collaborators

[object Object]